Companies /Healthcare

Charles River Laboratories International Inc

NYSE: CRL Diagnostics & Research
$293.16
▲ $1.40 (+0.48%) today
Markets closed · 4:50pm ET
Today · % change

24/7 Wall St. View

Fundamentals

Market Cap
$13.9B
Profit Margin
-6.0%
Revenue (TTM)
$4.0B
EPS (TTM)
$-4.96
52-Week Range
$144 – $303
Street Target
$281.00

About Charles River Laboratories

Charles River Laboratories International Inc is a global provider of essential services to the pharmaceutical and biotechnology industries. With a focus on advancing the drug discovery and development process, the company offers a comprehensive suite of services including research models, preclinical testing, and safety assessment. Its operations span across the United States, Europe, Canada, and the Asia Pacific, supporting clients from early-stage research to manufacturing solutions. Founded in 1947 and headquartered in Wilmington, Massachusetts, Charles River Laboratories is dedicated to helping its clients bring new therapies and medicines to the market efficiently.

CRL Coverage